Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Archives

You are currently viewing the 2010 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Details for NDA: 075355

« Back to Dashboard

NDA 075355 describes LABETALOL HYDROCHLORIDE, which is a drug marketed by Akorn Inc, Apotex Inc, Apothecon, Eurohlth Intl, Gland Pharma Ltd, Hospira, Ivax Sub Teva Pharms, Mutual Pharm, Par Form, Sandoz, Teva, and Watson Labs, and is included in fourteen NDAs. Additional details are available on the LABETALOL HYDROCHLORIDE profile page.

The generic ingredient in LABETALOL HYDROCHLORIDE is labetalol hydrochloride. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the labetalol hydrochloride profile page.

Summary for NDA: 075355

Tradename:
LABETALOL HYDROCHLORIDE
Applicant:
Apothecon
Ingredient:
labetalol hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Glossary

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE; INJECTIONStrength5MG/ML
Approval Date:Nov 29, 1999TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc